| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |